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Abstract
Background: Airway hyperresponsiveness (AHR) is one of the most prominent features of asthma,
however, precise mechanisms for its induction have not been fully elucidated. We previously reported that
systemic antigen sensitization alone directly induces AHR before development of eosinophilic airway
inflammation in a mouse model of allergic airway inflammation, which suggests a critical role of antigen-
specific systemic immune response itself in the induction of AHR. In the present study, we examined this
possibility by cell transfer experiment, and then analyzed which cell source was essential for this process.
Methods: BALB/c mice were immunized with ovalbumin (OVA) twice. Spleen cells were obtained from
the mice and were transferred in naive mice. Four days later, AHR was assessed. We carried out
bronchoalveolar lavage (BAL) to analyze inflammation and cytokine production in the lung. Fluorescence
and immunohistochemical studies were performed to identify T cells recruiting and proliferating in the lung
or in the gut of the recipient. To determine the essential phenotype, spleen cells were column purified by
antibody-coated microbeads with negative or positive selection, and transferred. Then, AHR was assessed.
Results: Transfer of spleen cells obtained from OVA-sensitized mice induced a moderate, but significant,
AHR without airway antigen challenge in naive mice without airway eosinophilia. Immunization with T
helper (Th) 1 elicited antigen (OVA with complete Freund's adjuvant) did not induce the AHR. Transferred
cells distributed among organs, and the cells proliferated in an antigen free setting for at least three days
in the lung. This transfer-induced AHR persisted for one week. Interleukin-4 and 5 in the BAL fluid
increased in the transferred mice. Immunoglobulin E was not involved in this transfer-induced AHR.
Transfer of in vitro polarized CD4+ Th2 cells, but not Th1 cells, induced AHR. We finally clarified that
CD4+CD62Llow memory/effector T cells recruited in the lung and proliferated, thus induced AHR.
Conclusion: These results suggest that antigen-sensitized memory/effector Th2 cells themselves play an
important role for induction of basal AHR in an antigen free, eosinophil-independent setting. Therefore,
regulation of CD4+ T cell-mediated immune response itself could be a critical therapeutic target for allergic
asthma.
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Background
Bronchial asthma is a chronic disorder characterized as
reversible airway obstruction, eosinophilic airway inflam-
mation, mucus hypersecretion, and airway hyperrespon-
siveness (AHR) [1]. In the process of airway
inflammation, various types of cells, such as eosinophils,
mast cells, T lymphocytes, and dendritic cells are involved
[2,3]. AHR to nonspecific stimuli is a hallmark of asthma.
However, the precise mechanism to induce AHR has not
been fully elucidated. Persistence of eosinophilic airway
inflammation is closely linked to induction of AHR
[1,4,5]. However, the dissociation of AHR and eosi-
nophilic airway inflammation often occurs [6-12]. For
example, Leckie et al. showed that administration of neu-
tralizing antibody (Ab) to interleukin (IL) -5 does not sup-
press AHR despite this treatment abrogating eosinophilia
in blood and sputum [6]. In addition, even a protective
role of eosinophils on the AHR induction has been
recently proposed in a mouse model [9]. These findings
suggest that other mechanism(s) than eosinophilic
inflammation would be involved in inducing AHR.
On the other hand, in patients with asthma, activated T
cells, especially CD4+ T helper (Th) 2 cells, also infiltrate
into the airway, which is associated with disease severity
[13-15]. In a mouse model, administration of blocking Ab
to CD4 suppresses AHR and airway inflammation
[11,16]. Moreover, transfer of CD4+ Th2 cells into naive
mice and subsequent antigen-inhalation induce AHR and
airway inflammation [17,18]. These findings suggest that
T cells, especially CD4+ Th2 cells, are also important for
the AHR induction. However, in these studies, AHR
induced by CD4+ Th2 cells accompanies eosinophilic air-
way inflammation. Therefore, it remains unclear whether
T cells alone could directly induce AHR.
We previously reported that systemic antigen sensitization
alone directly induces AHR before development of eosi-
nophilic inflammation in mice [19]. This raised a possi-
bility that systemic immune response to antigen itself
could directly induce AHR.
The purpose of the present study was to investigate which
component in the immunocompetent cells could directly
induce AHR. In this study, we found that passive cell
transfer of spleen cells obtained after antigen-sensitiza-
tion reconstituted AHR in naive mice. Then, using this sys-
tem, we studied the cell source essential for the AHR
induction, and confirmed that antigen-sensitized
CD4+CD62Llow memory/effector Th2 cells would play an
essential role for induction of basal AHR.
Methods
Immunization of mice and transfer of spleen cells
Mice were immunized as reported previously [19,20].
Seven-week-old male BALB/cAnNCrj mice (Charles River
Japan, Kanagawa, Japan) or IL-4 gene-deleted mice
(BALB/c-IL4tm2Nnt; Jackson Laboratory, Bar Harbor, ME)
were sensitized with an i.p. injection of 2 µg ovalbumin
(OVA; Sigma, St. Louis, MO), bovine serum albumin
(BSA; Wako, Osaka, Japan), or keyhole limpet hemocy-
anin (KLH; Calbiochem, LaJolla, CA) plus 2 mg alumi-
num hydroxide (alum) on days 0 and 11. Control mice
received an injection of physiologic saline (SA) without
alum on days 0 and 11. Some control mice received an
injection of SA plus alum. In some experiments, we used
complete Freund's adjuvant (CFA; Difco Laboratories,
Detroit, MI) instead of alum as an adjuvant. On day 18,
cell suspensions of spleens were obtained by pressing the
tissues through a 70-µm nylon filters. Spleen cells pre-
pared from the OVA-sensitized mice (1 × 106, 5 × 106, 2 ×
107, or 5 × 107 in 0.5 ml HBSS, respectively) or the SA-
treated mice (5 × 107) were transferred into syngenic
recipients by intravenous injection. In some experiments,
mice were sensitized with OVA on days 0 and 11, and
then challenged with 3% OVA for 10 minutes from day 18
to day 20. On day 21, lungs were excised to observe eosi-
nophilic airway inflammation. All animal experiments
were approved by the Animal Research Ethics Board of the
Department of Allergy and Rheumatology, University of
Tokyo.
Measurement of airway responsiveness (AR)
On day 22 (4 days after the transfer), AR to methacholine
(Mch) was measured with the enhanced pause (Penh) sys-
tem (Buxco, Troy, NY) as described previously [19,20]. In
some experiments, AR was assessed by measurement of
airway resistance (Raw) [21,22]. Briefly, anesthetized
mice were tracheostomized and connected to a MiniVent
ventilator (Hugo Sachs Elektronik, March, Germany),
then ventilated with a tidal volume of 250 µl and a respi-
ratory frequency of 120 breaths/minute. The mice were
placed inside whole-body plethysmographs (Buxco) to
measure Raw. Increasing doses of Mch were administered
by ultraneblization for 3 minutes. The concentration of
Mch that induced a 100% increase in Penh or Raw was
expressed as PC200Mch (µg/ml) or PC200Mch Raw (µg/ml)
as an indicator of AHR.
Bronchoalveolar lavage (BAL) and histological 
examination
Bronchoalveolar lavage fluid (BALF) analyses were per-
formed as described previously [19,20]. The lungs were
lavaged four times with SA (0.5 ml each), and approxi-
mately 1.6 ml was consistently recovered with gentle han-
dling. The cell suspension was centrifuged at 1,500 rpm
for 10 minutes at 4°C. The cells were resuspended into 1Respiratory Research 2005, 6:46 http://respiratory-research.com/content/6/1/46
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ml of saline with 1% BSA, and the total cell numbers were
counted with a hemocytometer. Cytospin samples were
prepared by centrifuging the suspensions (200 µl) at 300
rpm for 10 minutes. To clearly distinguish eosinophils
from the neutrophils, three different stains were applied:
Diff-Quick stain, May-Grünwald-Giemsa stain, and
Eosino (Hansel) stain [19]. On the basis of the findings
with these stainings, cell differentials were counted with at
least 300 leukocytes in each sample. Lung histological
examinations were performed as described previously
[19,20]. Serum immunoglobulin (Ig) E and BALF
cytokine concentrations were measured using ELISA kits
(Pharmingen, SanDiego, CA) according to the manufac-
turer's instructions. The lower limits of sensitivity for the
ELISA were 78 ng/ml (IgE), 7.8 pg/ml (IL-4), 15.6 pg/ml
(IL-5), and 31.2 pg/ml (interferon (IFN)-γ ), respectively.
Fluorescence study and immunohistochemistry
On day 18, spleen cells (5 × 107) from OVA-sensitized
mice were labeled with fluorescent dye (PKH67; Sigma),
and then transferred into syngenic recipients. In another
experiment, CD4+CD62Llow cells (4 × 106) from OVA-sen-
sitized mice were positively selected as described in
"depletion and positive selection study", and then labeled
and transferred. On day 19, after perfusion with saline,
lungs were excised. Five-micrometer sections were cut and
observed by fluorescence microscopy (BX51; Olympus,
Melville, NY). Immunohistochemistry was performed
using Vectastain ABC kits (Vector Laboratories, Burlin-
game, CA) as described previously [23]. T cells were
detected by staining for CD3 (cytoplasm, blue). Prolifera-
tion was assessed by staining for proliferating cell nuclear
antigen (PCNA; nucleus, brown). Double-staining analy-
sis of a single section was performed. Briefly, the tissue
was deparaffinized and rehydrated with decreasing con-
centrations of ethyl alcohol. The slides were boiled in 0.05
M citric acid for 7 minutes. After cooling down to room
temperature, endogenous peroxidase activity was blocked
by incubating the slides in 3% H2O2 in methanol for 60
minutes. Next the slides were treated with blocking solu-
tion containing 5% normal rabbit serum, 2% casein, and
3% BSA for 45 minutes. Anti-CD3 Ab (5 µg/ml; Santa
Cruz Biotechnology, Santa Cruz, CA) was applied to the
tissue and incubated at 37°C for 30 minutes. After wash-
ing with PBS, biotinylated rabbit anti-goat IgG Ab was
applied and incubated at 37°C for 30 minutes. After
washing, avidin-biotin alkaline phosphatase complex was
applied and incubated at 37°C for 30 minutes, followed
by the addition of substrate solution. Color development
was stopped by rinsing the slides in distilled water. Then,
the slides were treated with blocking solution containing
5% normal goat serum, 2% casein, and 3% BSA for 45
minutes. Anti-PCNA Ab (2 µg/ml; Santa Cruz Biotechnol-
ogy) was applied to the tissue and incubated at 37°C for
30 minutes. After washing with PBS, biotinylated goat
anti-mouse IgG Ab was applied and incubated at 37°C for
30 minutes. After washing, avidin-biotin peroxidase com-
plex was applied and incubated at 37°C for 30 minutes,
followed by the addition of diaminobenzidine solution.
Color development was stopped by rinsing the slides in
distilled water. The slides were counterstained with neu-
tral red. Positively immunostained cells were enumerated
directly in 20 random high power fields (hpf; 40×
objective).
Depletion and positive selection study
For depletion, on day 18, spleen cells from OVA-sensi-
tized mice were incubated with biotinylated anti-CD4
monoclonal antibody (mAb; RM4-5; Pharmingen), anti-
CD8 mAb (53-6.7; Pharmingen), anti-CD11b mAb (M1/
70; Pharmingen), anti-CD11c mAb (HL3; Pharmingen),
or anti-CD19 mAb (1D3; Pharmingen), and then incu-
bated with streptavidin-microbeads (Miltenyi Biotech,
Bergisch Gladbach, Germany). For depletion of invariant
Vα 14 (iVα 14) natural killer T (NKT) cells, spleen cells
from OVA-sensitized mice were incubated with α -galacto-
sylceramide (α -GalCer; kindly provided by the Pharma-
ceutical Research Laboratory of Kirin Brewery Company,
Gunma, Japan)-loaded mouse CD1d: Ig dimeric protein
(Pharmingen) and then incubated with anti-mouse IgG1-
microbeads (Miltenyi Biotech). Bead-bound cells were
depleted using magnetic separation columns. Flow
cytometry confirmed that greater than 98% of CD4+,
CD8+, CD11b+, CD11c+, or CD19+ cells were removed
from splenocytes, and 88% of cells that bound α -GalCer-
loaded mouse CD1d dimer were removed (data not
shown). Syngenic recipients received CD4+, CD8+,
CD11b+, CD11c+, CD19+, or iVα 14 NKT cell-depleted
splenocytes (5 × 107 each). For positive selection, on day
18, spleen cells from OVA-sensitized mice were incubated
with anti-CD4 mAb-coated or anti-CD11c mAb-coated
microbeads (Miltenyi Biotech). Bead-bound cells were
then isolated using magnetic separation columns. The
purities of the enriched CD4+ and CD11c+ cells were 95%
and 85%, respectively (data not shown). Over 95% of the
CD4+ cells were CD3+ T cells (data not shown). Syngenic
recipients received CD4+ (1.25 × 107) or CD11c+ (1 × 106)
cells. We prepared a CD4+CD62Llow  subset or a
CD4+CD62Lhigh subset using an anti-FITC multisort kit
(Miltenyi Biotech), FITC anti-CD4 mAb (RM4-5;
Pharmingen), and anti-CD62L mAb-coated microbeads
(Miltenyi Biotech). The purities of each subset were 80%
(data not shown). Syngenic recipients received
CD4+CD62Llow (4 × 106) or CD4+CD62Lhigh (8.5 × 106)
cells. AR was measured on day 22 (4 days after the
transfer).Respiratory Research 2005, 6:46 http://respiratory-research.com/content/6/1/46
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In vitro OVA stimulation and polarization to Th1 or Th2 
phenotype
On day 18, spleen cells (5 × 106 cells/ml) from OVA-sen-
sitized mice were incubated with OVA (200 µg/ml) for 4
days in vitro. On day 22, syngenic recipients received these
stimulated cells (1 × 106). In some experiments, dead cells
were removed from cultured splenocytes using Percoll
(Pharmacia Biotech, Uppsala, Sweden) gradient centrifu-
gation. For polarization to Th1 cells, recombinant IL-12
(10 ng/ml; Genzyme Techne, Minneapolis, MN) and anti-
IL-4 Ab (0.1 µg/ml; Genzyme Techne) were added to the
culture medium. For polarization to Th2 cells, recom-
binant IL-4 (100 ng/ml; Genzyme Techne) and anti-IL-12
Ab (0.25 µg/ml; Genzyme Techne) were added. Polariza-
tion was confirmed by measuring IL-4 and IFN-γ  in super-
natant using ELISA. On day 22, CD4+  T cells were
positively selected, and syngenic recipients received CD4+
Th1 cells or CD4+ Th2 cells (5 × 105 each). AR was meas-
ured on day 26 (4 days after the transfer).
In vitro proliferation and cytokine assays
Positively selected CD4+ T cells, CD4+CD62Lhigh T cells,
and CD4+CD62Llow T cells (2.5 × 105 cells/well, respec-
tively) from OVA-sensitized mice were cultured with
freshly isolated mitomycin C (Sigma)-treated splenocytes
(2.5 × 105 cells/well) in the presence or absence of OVA.
After 48 hours, the proliferation was assessed by a cell pro-
liferation ELISA bromodeoxyuridine (BrdU) kit (Roche
Applied Science, Mannheim, Germany). After 72 hours,
cytokine concentrations in the supernatants were meas-
ured using ELISA.
Statistics
Values are expressed as means ± SEM. Statistical analysis
was performed by one-way ANOVA followed by Fisher's
least significant difference test or Student's t test. A p value
< 0.05 was considered significant.
Results
Passive cell transfer of spleen cells from antigen-sensitized 
mice induces AHR
As reported previously [19], immunization with OVA
alone induced a significant increase in AR (OVA ip;
PC200Mch; 3,870 ± 518 µg/ml) as compared with saline
injection (SAip; 5,725 ± 1,009 µg/ml; Figure 1A). Injec-
tion with alum alone provoked a slight non-specific
increase in AR, but it was not significant (data not shown).
When OVA-sensitized mice received OVA inhalation chal-
lenges, then prominent infiltration of eosinophils was
provoked and AR further increased (OVA/OVA; 2,564 ±
343 µg/ml; Figure 1A). In the group of mice that received
spleen cells from OVA-sensitized mice (defined as
"TROVA-mice"; 5 × 107), PC200Mch was 4,191 ± 203 µg/
ml, which was significantly lower than that of the group
of mice that received the same number of spleen cells
from SA-treated mice (defined as "TRSA-mice"; 5 × 107;
6,357 ± 835 µg/ml; Figure 1A). Transfer of spleen cells
from mice that were injected with SA plus alum did not
induce AHR (TRAlum; 6,596 ± 697 µg/ml). Therefore,
transfer of OVA-sensitized spleen cells reconstituted mod-
erate AHR in a naive mouse to a similar degree of AHR
induced by systemic sensitization with OVA antigen. In
the TROVA-mice, AR increased in a cell-number depend-
ent-manner (Figure 1B; 7,415 ± 2,176 µg/ml (1 × 106),
6,343 ± 1,392 µg/ml (5 × 106), 4,803 ± 572 µg/ml (2 ×
107), respectively). To confirm the reliability of the data
obtained from the Penh system, we examined AR by
measuring Raw with ventilated mice treated with the same
immunization protocol. Similar results on AHR were
obtained by measuring Raw (Figure 1C; PC200Mch Raw;
SAip, 47,205 ± 4,767 µg/ml, OVA ip, 20,668 ± 1,562 µg/
ml, TRSA, 46,702 ± 6,653 µg/ml, TROVA, 22,450 ± 9,535
µg/ml). So we used Penh system for the following experi-
ments. In a time course study, the TROVA-mice revealed a
significant increase in AR from 4 to 10 days after the trans-
fer (Figure 2).
Antigens that elicit Th2-type, but not Th1-type, immune 
response can induce AHR by cell transfer
Next we confirmed other antigens than OVA could also
induce AHR. Transfer of spleen cells from BSA-sensitized
mice or KLH-sensitized mice also induced a significant
AHR (Figure 3A; TRSA, 5,814 ± 638 µg/ml, TROVA, 4,112
± 147 µg/ml, TRAlum, 6,224 ± 680 µg/ml, TRBSA, 4,633
± 279 µg/ml, TRKLH, 4,123 ± 280 µg/ml). In another
experiment, we confirmed systemic sensitization alone
with BSA or KLH induced AHR without eosinophilic
inflammation (data not shown). We also confirmed that
systemic sensitization with BSA or KLH increased serum
IgE concentration (data not shown). When BSA or KLH
sensitized mice received airway antigen challenge, eosi-
nophilic airway inflammation was provoked (data not
shown). On the other hand, use of CFA instead of alum as
an adjuvant, which is known to elicit Th1-type immunity
[24], did not induce transfer-mediated AHR (Figure 3B;
TRSA, 5,814 ± 638 µg/ml, TROVA/Alum, 4,112 ± 147 µg/
ml, TROVA/CFA, 5,224 ± 74 µg/ml, TRCFA, 5,708 ± 945
µg/ml). Therefore, it could be generally considered that
antigens that elicit Th2-type immune response could
induce a significant AHR by cell transfer.
The transfer-mediated AHR is provoked in an eosinophil-
independent manner
In the TROVA-mice, the number of total cell, macrophage,
and lymphocyte in BALF slightly increased, whereas eosi-
nophil number did not (Table 1). In the TROVA-mice, a
slight infiltration of inflammatory cells into the peribron-
chial area was detected in some specimens. However,
prominent infiltration of eosinophils was not detected
(Figure 4A, left). In contrast, in the OVA-sensitized andRespiratory Research 2005, 6:46 http://respiratory-research.com/content/6/1/46
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Passive cell transfer of spleen cells from OVA-sensitized mice induces airway hyperresponsiveness (AHR) Figure 1
Passive cell transfer of spleen cells from OVA-sensitized mice induces airway hyperresponsiveness (AHR). (A) 
Transfer of spleen cells from OVA-sensitized mice induces a moderate AHR. Mice were sensitized with OVA or SA on days 0 
and 11. On day 18, recipients received the spleen cells (5 × 107) from SA (without alum)-treated mice (TRSA), OVA-sensitized 
mice (TROVA), or SA (with alum)-treated mice (TRAlum). Airway responsiveness (AR) to methacholine (Mch) was measured 
with Penh methods on day 22 (4 days after the transfer) as described in Methods. Some OVA-sensitized mice were inhaled 
with OVA from day 18 to day 20. AR was measured on day 18 in mice received that i.p SA injection (SAip) or OVA injection 
only (OVAip), or on day 21 in mice that received OVA-sensitization and -inhalation (OVA/OVA). Values are presented as 
means ± SEM for 5 to 14 mice per group. * p < 0.05 compared with PC200Mch of TRSA (5 × 107). # p < 0.05 compared with 
PC200Mch of SAip. (B) AR to Mch increases in a transferred-cell-number-dependent manner (n = 5–14 per group). Recipients 
received spleen cells from SA-treated mice (TRSA; 5 × 107) or OVA-sensitized mice (TROVA; 1 × 106, 5 × 106, 2 × 107, or 5 × 
107). AR was measured 4 days after the transfer. * p < 0.05 compared with PC200Mch of TRSA (5 × 107). (C) AR was assessed 
by measurement of airway resistance (Raw) (n = 6–12 per group). * p < 0.05 compared with PC200Mch Raw of TRSA (5 × 107). 
# p < 0.05 compared with PC200Mch Raw of SAip.
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challenged mice (OVA/OVA), prominent infiltration of
eosinophils into the peribronchial interstitial area or
bronchial wall was observed (Figure 4A, right). These
results indicated that cell transfer induced AHR without
prominent infiltration of eosinophils in the lung.
Some transferred cells recruit into the lung, and some T 
cells proliferate without further airway antigen challenge
We next analyzed lung sections from mice that received
fluorescently labeled spleen cells from OVA-sensitized
mice. The transferred cells were clearly detected in the
lung 24 hours after the transfer, particularly in lung inter-
stitial areas (Figure 4B, left). In contrast, the mice that had
not received cell transfer did not show this finding (Figure
4B, right). Similar results were observed 3 days after the
transfer (data not shown). Immunohistochemistry
revealed that some T cells in the lung proliferated without
further airway antigen challenge in the TROVA-mice (1.6
± 0.2/hpf; Figure 4C, left). In contrast, in the TRSA-mice,
proliferation of T cells was less detected (0.5 ± 0.1/hpf;
Figure 4C, right).
Transferred cells also distribute in other tissues and induce 
mild inflammation
In the TROVA-mice, a slight infiltration of inflammatory
cells was also detected in the mucosa of colon in some
specimens (Figure 4D, left). In contrast, it was less
detected in the TRSA-mice (Figure 4D, right). Similar
results were obtained in tissues other than colon such as
stomach and small intestine (data not shown). Fluores-
cence study revealed that transferred cells also distributed
among other tissues such as colon (Figure 4E), stomach,
liver, and spleen (data not shown). Therefore, transferred
cells did not recruit specifically into the lung, but distrib-
uted throughout the body.
Change in AHR following cell transfer Figure 2
Change in AHR following cell transfer. Recipients 
received spleen cells (5 × 107) from SA-treated mice (TRSA) 
or OVA-sensitized mice (TROVA). AR was measured at the 
indicated time after the transfer (n = 8 per group). ## p < 
0.01 compared with the baseline value (before the transfer) 
(ANOVA). * p < 0.05 compared with PC200Mch at the same 
time point of TRSA.
* *
P
C
2
0
0
M
c
h
(
µ
g
/
m
l
)
Time after transfer (days)
04 7 1 0 1 4
## ## ##
0
2,000
4,000
6,000 TRSA TROVA
Antigens that elicit Th2 type response, but not Th1 type  response, induce transfer-mediated AHR Figure 3
Antigens that elicit Th2 type response, but not Th1 
type response, induce transfer-mediated AHR. (A) 
Antigens that elicit Th2 type response induce transfer-medi-
ated AHR. Recipients received spleen cells (5 × 107) from SA 
(without alum)-treated mice (TRSA), from OVA-sensitized 
mice (TROVA), from SA (with alum)-treated mice (TRAlum), 
from BSA-sensitized mice (TRBSA), or from KLH-sensitized 
mice (TRKLH). AR was measured 4 days after the transfer (n 
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Th2 cell-type cytokines, but not IgE, mediate transfer-
induced AHR
In the TROVA-mice (5 × 107), the concentrations of IL-4
and IL-5 were significantly higher than those of the TRSA-
mice (5 × 107) (Figure 5A). The concentrations of IL-13
(data not shown) and IFN-γ  levels (Figure 5A) also slightly
increased in the TROVA-mice (5 × 107), but these values
were not significantly different from those of the TRSA-
mice (5 × 107). Thus, Th2 cell-type cytokines increased in
BALF, and their increases might play a pivotal role in the
transfer-mediated AHR. We also measured serum IgE con-
centration. No significant increase in IgE was detected
(Figure 5B), suggesting that IgE did not mediate transfer-
induced AHR.
IL-4 plays an important role in transfer-mediated AHR
As reported previously [19], IL-4 played a pivotal role in
AHR that induced by antigen sensitization alone. So, we
next examined the role of IL-4 in this transfer-mediated
AHR. Transfer of spleen cells from OVA-sensitized, IL-4-
deficient mice failed to induce the development of AHR
(Figure 6; TRSA, 6,554 ± 758 µg/ml, TROVA, 4,209 ± 287
µg/ml, TRSA/IL-4-/-, 6,723 ± 765 µg/ml, TROVA/IL-4-/-,
6,593 ± 698 µg/ml) and an increase in BALF IL-4 concen-
tration was not detected (data not shown). These results
suggested that IL-4 production by OVA-sensitized spleen
cells played an important role in the induction of transfer-
mediated AHR.
In vitro OVA stimulation potentiates the intensity of 
transfer-mediated AHR
In another experiment, OVA-sensitized spleen cells were
stimulated with OVA in vitro and then transferred. This
treatment increased the intensity of transfer-mediated
AHR (Figure 7A; TRSA, 6,556 ± 703 µg/ml, TROVA (1 ×
106), 6,848 ± 997 µg/ml, TROVA (5 × 107), 4,607 ± 205
µg/ml, stimulated cell-transferred mice (TRSTIM) (1 ×
106), 3,654 ± 459 µg/ml). BALF cytokine concentrations
of the recipients were also increased by this treatment
(Figure 7B). This result indicated that stronger antigen
stimulus induced stronger immune response, which
resulted in the induction of higher AHR.
CD4+ Th2 cells induce AHR
To determine which cells are most important for this AHR
induction, we carried out a cell depletion study. Transfer
of CD4+ cell-depleted splenocytes into naive mice failed
to induce the development of AHR (Figure 8A; TRSA,
6,240 ± 577 µg/ml, TROVA, 3,858 ± 325 µg/ml, CD4 (-),
5,695 ± 543 µg/ml, CD8 (-), 3,738 ± 368 µg/ml, CD11b
(-), 3,528 ± 327 µg/ml, CD11c (-), 4,077 ± 206 µg/ml,
CD19 (-), 3,694 ± 434 µg/ml, iVα 14 NKT (-), 3,497 ± 345
µg/ml) or failed to increase BALF cytokine concentrations
(data not shown). We next carried out positive selection.
We determined the numbers of CD4+ and CD11c+ spleen
cells to be transferred based on the physiologic ratio of
these cells (CD4+ spleen cells were 25% and CD11c+
spleen cells were 2% of total spleen cells, respectively).
Transfer of positively selected CD4+ T cells into naive mice
induced AHR (Figure 8B; TRSA, 7,061 ± 831 µg/ml,
TROVA, 4,381 ± 102 µg/ml, CD4, 4,526 ± 560 µg/ml,
CD11c, 5,637 ± 1,040 µg/ml) and an elevation of BALF
cytokine levels (data not shown), which were consistent
with the results of depletion study. Next, we elucidated
which of the two CD4-mediated response play a major
role for AHR induction. Spleen cells were polarized to
either Th1 or Th2 phenotype (Figure 8C) and each
CD4+population was transferred. Transfer of CD4+ Th2,
but not Th1, cells induced AHR (Figure 8D; Th1, 5,732 ±
508 µg/ml, Th2, 4,384 ± 151 µg/ml).
CD4+CD62Llow memory/effector T cells play an essential 
role in the transfer-induced AHR
The results obtained so far indicated that antigen-stimu-
lated CD4+ Th2 cells reached the lung and proliferated
there, then produced Th2-type cytokine, which resulted in
the direct induction of AHR. They also indicated that anti-
gen-pulsed memory/effector T cell phenotype might play
an important role in the transfer-mediated AHR induc-
tion. So, finally we examined their role in our system.
CD4+CD62Lhigh T cells and CD4+CD62Llow T cells were
prepared by Ab-coated microbeads and column separa-
tion. In an in vitro study, the CD62Llow memory/effector
subset proliferated and produced Th2-type cytokines in
response to OVA, whereas the CD62Lhigh subset did not
Table 1: BALF findings
Total cells(×102) Macrophage(×102) Lymphocyte(×102) Neutrophil(×102) Eosinophil(×102)
TRSA 5 × 106 919 ± 115 893 ± 111 25 ± 6 1 ± 1 0 ± 0
TROVA 1 × 106 980 ± 149 945 ± 140 33 ± 7 3 ± 3 0 ± 0
TROVA 5 × 106 1070 ± 132 1030 ± 132 34 ± 4 6 ± 4 0 ± 0
TROVA 2 × 107 950 ± 78 898 ± 77 44 ± 7 6 ± 2 3 ± 1
TROVA 5 × 107 1004 ± 105 942 ± 98 55 ± 11 6 ± 2 1 ± 1
Values are presented as means ± SEM for 5 to 14 mice per group.Respiratory Research 2005, 6:46 http://respiratory-research.com/content/6/1/46
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Histologic findings Figure 4
Histologic findings. (A) H&E stain. Lung sections from mice that received spleen cells from OVA-sensitized mice (TROVA) 
and from mice that received OVA-sensitization and aerosol OVA-challenge (OVA/OVA) are shown. Scale bar, 200 µm. (B) Flu-
orescence study. Spleen cells from OVA-sensitized mice were labeled with fluorescent dye (PKH67), and then transferred into 
recipients. Five-micrometer sections of the lungs were observed by fluorescence microscopy 24 hours after the transfer 
(TROVA). A lung section from naive mice without transfer is shown (naive). Scale bar, 100 µm. (C) Double staining analysis of 
a single section by immunohistochemistry. T cells were detected by staining for CD3 (cytoplasm, blue). Proliferation was 
assessed by staining for PCNA (nucleus, brown). Lung sections from mice that received spleen cells from OVA-sensitized mice 
(TROVA) and from mice that received spleen cells from SA-treated mice (TRSA) are shown. Proliferating T cells were clearly 
detected (black arrow). Scale bar, 40 µm. (D) Histologic findings of colon (H&E stain). Colon sections from mice that received 
spleen cells from OVA-sensitized mice (TROVA) and from SA-treated mice (TRSA) are shown. Scale bar, 200 µm. (E)Trans-
ferred cells recruit into the colon. Spleen cells from OVA-sensitized mice were labeled, and transferred. Five-micrometer sec-
tions of the colons were observed by fluorescence microscopy 24 hours after the transfer (TROVA). A colon section from 
naive mice without transfer is shown (naive). Scale bar, 100 µm.
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Concentrations of BALF cytokines and serum IgE Figure 5
Concentrations of BALF cytokines and serum IgE. (A) BALF cytokine concentrations. Four days after the transfer, BAL 
was performed and then the centrifuged supernatant was assayed for IL-4, IL-5, and IFN-γ  concentrations by ELISA, respec-
tively (n = 5–14 per group). * p < 0.05 compared with the values of TRSA (5 × 107). (B) Serum IgE concentrations (n = 5–14 
per group). *** p < 0.001 compared with the values of SAip.
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(Figure 9A and 9B). Moreover, the CD62Llow memory/
effector subset from OVA-sensitized mice produced Th2-
type cytokines even without further antigen stimulation,
although the values were low (data not shown). Then, we
performed transfer study. We determined the numbers of
CD62Lhigh and CD62Llow cells to be transferred based on
the physiologic ratio of these phenotypes (CD62Lhigh cells
were 68% and CD62Llow cells were 32% of splenic CD4+ T
cells, respectively). Transfer of the CD62Llow memory/
effector subset, but not the CD62Lhigh subset, induced
AHR (Figure 9C; CD4, 3,968 ± 258 µg/ml, CD62Lhi,
6,549 ± 645 µg/ml, CD62Llo, 3,824 ± 420 µg/ml). When
we evaluated AHR by measuring Raw, similar results were
obtained (Figure 9D; PC200Mch Raw; CD4, 23,840 ±
3,350 µg/ml, CD62Lhi, 41,146 ± 6,451 µg/ml, CD62Llo,
22,146 ± 6,150 µg/ml). We also confirmed that some
transferred CD4+CD62Llow cells actually recruited into the
lung (Figure 9E). Moreover, in the mice that received the
CD62Llow subset, some T cells in the lung proliferated
there without further antigen stimulation (Figure 9F).
These results strongly indicated that CD4+CD62Llow mem-
ory/effector T cells were essential for this transfer-medi-
ated, antigen-induced AHR.
Discussion
In the current study, we demonstrated that transfer of
antigen-induced cellular immune response into naive
mice reconstituted AHR in an antigen free setting. We
found that CD4+CD62Llow Th2 cells play an essential role
in this process. Our results strongly suggest that in sensi-
tized individuals, memory/effector T cells could reach the
lung tissue and locally act on the airways, thus would
directly induce and maintain basal AHR independently of
eosinophils, although the intensity could be moderate.
AHR is one of the most characteristic features of asthma
[1]. However, the precise mechanism for its induction has
not been fully clarified. It is considered that eosinophilic
airway inflammation is closely linked to the AHR
induction [1,4,5]. However, a causal link between eosi-
nophilic airway inflammation and AHR has not been
established. On the other hand, CD4+ T cells, especially
CD4+ Th2 cells, are also involved in the induction of AHR
[11,13-18]. However, the significance of eosinophils or
CD4+ T cells on the AHR induction has been clarified only
in the effector phase, under the condition of airway anti-
gen challenge. Therefore, the role of these cells in the AHR
induction has not been evaluated in an antigen free set-
ting. We previously reported that systemic antigen sensiti-
zation alone directly induces AHR before development of
eosinophilic airway inflammation [19]. In addition, in
the current study, transfer of spleen cells obtained from
antigen-sensitized mice induced a significant AHR in
naive mice without airway eosinophilia (Figure 1, Figure
3, Figure 4A, and Table 1). These results indicate that anti-
gen-sensitized spleen cells could directly induce AHR. In
humans, we previously reported that some patients with
atopic dermatitis who are highly sensitized to mite anti-
gen have a moderate AHR regardless of the lack of any his-
tory of asthma [25]. This would support the speculation
that sensitization to an antigen could directly induce AHR
also in humans.
We measured AR mainly by Penh system throughout the
current study. Penh system has been widely used for meas-
urement of AR to Mch in BALB/c mice [19,20,26]. Meas-
uring Penh is superior to measuring Raw of ventilated
mice in terms of its conciseness and non-invasiveness. In
addition, sampling bias caused by maneuver in Penh sys-
tem seemed to be lower than that in invasive ventilator
system. Based on these advantages of Penh system, we
could measure AR of large numbers of mice simultane-
ously with a good reproducibility. However, the accuracy
of Penh as an indicator of AR has been recently criticized
because Penh does not correlate with Raw especially in
C57BL/6 mice [27-29]. Measuring Penh is more fre-
quently affected by the heat and humidification than
measuring Raw [30,31]. Considering these experimental
and theoretical problems, we also examined AR by
IL-4 plays an important role in transfer-mediated AHR Figure 6
IL-4 plays an important role in transfer-mediated 
AHR. Recipients received spleen cells (5 × 107) from SA-
treated wild-type mice (TRSA), from OVA-sensitized wild-
type mice (TROVA), from SA-treated IL-4-deficient mice 
(TRSA/IL-4-/-), or from OVA-sensitized IL-4-deficient mice 
(TROVA/IL-4-/-). AR was measured 4 days after the transfer 
(n = 6–8 per group). * p < 0.05 compared with PC200Mch of 
TRSA. # p < 0.05 compared with PC200Mch of TROVA.
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In vitro OVA stimulation increases the intensity of transfer-mediated AHR Figure 7
In vitro OVA stimulation increases the intensity of transfer-mediated AHR. (A) Effect of in vitro OVA stimulation on 
transfer-mediated AHR. On day 18, spleen cells (5 × 106 cells/ml) from OVA-sensitized mice were incubated with OVA (200 
µg/ml) for 4 days in vitro. On day 22, recipients received these stimulated cells by intravenous injection (TRSTIM: 1 × 106). AR 
was measured 4 days after the transfer (n = 5–10 per group). * p < 0.05 compared with PC200Mch of TRSA (5 × 107). # p < 
0.05 compared with PC200Mch of TROVA (1 × 106). (B) BALF cytokine concentrations. Four days after the transfer, BAL was 
performed and then the centrifuged supernatant was assayed for IL-4, IL-5, and IFN-γ  concentrations using ELISA, respectively 
(n = 5–10 per group). * p < 0.05 compared with the values of TRSA (5 × 107). # p < 0.05 compared with the values of TROVA 
(1 × 106).
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CD4+ Th2 cells directly induce AHR Figure 8
CD4+ Th2 cells directly induce AHR. (A) Depletion study. Recipients received spleen cells (5 × 107) from SA-treated mice 
(TRSA) or OVA-sensitized mice (TROVA). Other recipients received CD4+cell-depleted (CD4(-)), CD8+ cell-depleted (CD8(-
)), CD11b+ cell-depleted (CD11b(-)), CD11c+ cell-depleted (CD11c(-)), CD19+ cell-depleted (CD19(-)), or iVα 14 NKT cell-
depleted (iVα 14 NKT(-)) spleen cells from OVA-sensitized mice (5 × 107 each), respectively. AR was measured 4 days after the 
transfer (n = 6–10 per group). * p < 0.05 compared with PC200Mch of TROVA. (B) Effect of CD4+ or CD11c+ cells on transfer-
mediated AHR. Recipients received unfractionated spleen cells from SA-treated mice (TRSA; 5 × 107), or unfractionated 
(TROVA; 5 × 107), CD4+ (CD4; 1.25 × 107), or CD11c+ (CD11c; 1 × 106) spleen cells from OVA-sensitized mice. AR was 
measured 4 days after the transfer (n = 5–8 per group). * p < 0.05 compared with PC200Mch of TRSA. (C) Polarization to Th1 
or Th2 phenotype. On day 18, spleen cells (5 × 106 cells/ml) from OVA-sensitized mice were incubated with OVA (200 µg/ml) 
for 4 days in vitro. For polarization toward Th1 cells, IL-12 and anti-IL-4 Ab were added to the culture medium. For polarization 
toward Th2 cells, IL-4 and anti-IL-12 Ab were added. On day 22, positively selected CD4+ T cells were cultured with freshly 
isolated mitomycin C-treated splenocytes and OVA (200 µg/ml). After 96 hours, IL-4 and IFN-γ  concentrations in the superna-
tants were assayed. *** p < 0.001 compared with the value of the CD4+ Th1 cells. ### p < 0.001 compared with the value of 
the CD4+ Th2 cells. (D) Effect of Th1 or Th2 phenotype on transfer-mediated AHR. Recipients received CD4+ Th1 or Th2 
cells (5 × 105). AR was measured 4 days after the transfer (n = 5–6 per group). * p < 0.05 compared with PC200Mch of mice 
that received CD4+ Th1 cells.
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CD4+CD62Llow memory/effector subset produces Th2-type cytokines and directly induces transfer-mediated AHR Figure 9
CD4+CD62Llow memory/effector subset produces Th2-type cytokines and directly induces transfer-mediated 
AHR. (A and B)CD4+CD62Llow memory/effector subset proliferates and produces Th2-type cytokines with antigen stimula-
tion. On day 18, CD4+ T cells (CD4), CD4+CD62Lhigh T cells (CD62Lhi), or CD4+CD62Llow T cells (CD62Llo) from OVA-sen-
sitized mice were positively selected by magnetic cell sorting as described in Methods. Then, these cells were cultured with 
freshly isolated mitomycin C-treated splenocytes in the presence of OVA. After 48 hours, the proliferation was assessed by 
BrdU incorporation using ELISA (A). The maximum proliferation observed in response to OVA for CD4+CD62Llow T cells 
from OVA-sensitized mice was set as control (100%). After 72 hours, Th2-type cytokine levels in the supernatants were 
assayed using ELISA (B). *** p < 0.001 compared with the value of CD4+CD62Lhigh T cells. (C and D) CD4+CD62Llow memory/
effector T cells induce AHR. Recipients received CD4+ (CD4; 1.25 × 107), CD4+CD62Lhigh (CD62Lhi; 8.5 × 106), or 
CD4+CD62Llow (CD62Llo; 4 × 106) cells from OVA-sensitized mice. AR was measured 4 days after the transfer. (C) AR was 
measured by Penh methods (n = 5–6 per group). * p < 0.05 compared with PC200Mch of mice that received CD4+CD62Lhigh T 
cells. (D) AR was assessed by measurement of Raw (n = 6–8 per group). * p < 0.05 compared with PC200Mch Raw of mice that 
received CD4+CD62Lhigh T cells. (E)Fluorescence study. CD4+CD62Llow cells from OVA-sensitized mice (4 × 106) were labeled 
with fluorescent dye, and then transferred into recipients. Five-micrometer sections of the lungs were observed by fluores-
cence microscopy 24 hours after the transfer (CD62Llo). Scale bar, 100 µm. (E) Double staining analysis by immunohistochem-
istry. T cells were detected by staining for CD3 (cytoplasm, blue). Proliferation was assessed by staining for PCNA (nucleus, 
brown). Lung sections from mice that received OVA-sensitized CD4+CD62Llow cells (CD62Llo; 4 × 106) are shown. Proliferat-
ing T cells were clearly detected (black arrow). Scale bar, 40 µm.
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measuring Raw with ventilated mice in the most impor-
tant experiments (Figures 1C and 9D). We confirmed that
similar results were obtained by the two systems. There-
fore, we considered that the data obtained from the Penh
system in the current study were, to a certain extent,
reliable.
Next we studied the mechanism of the cell transfer-
induced AHR. The fluorescence study and double staining
demonstrated that these transferred cells reached the lung
and some T cells actually proliferated in the lung without
further airway antigen challenge (Figure 4B and 4C).
Byersdorfer et al. reported that some transferred Th1 cells
migrate in the airway before antigen challenge [32]. Julia
et al. reported that antigen sensitization alone distributes
antigen-specific T cells in the BALF and in the lung [33].
These reports support the present findings. Therefore,
some antigen specific T cells could have reached the lung
in an antigen free setting. On the other hand, transferred
cells reached the tissues other than lung such as colon,
which induced a slight inflammation there (Figure 4D
and 4E). These results suggested that antigen sensitization
or transfer of antigen-sensitized spleen cells would
distribute antigen-specific T cells among tissues, and thus
could induce some immure response there even without
local antigen challenge.
The result of BALF cytokine concentrations (Figure 5A)
and transfer of CD4+ Th2 cells (Figure 8D) demonstrated
that CD4+  Th2 cells played an essential role in the
induction of the AHR. In addition, results from positive
and negative selection studies clarified that
CD4+CD62Llow T cells were essential for transfer-induced
AHR induction, while other phenotypes such as
CD4+CD62Lhigh T cells or iVα 14 NKT cells were not (Fig-
ures 8 and 9). There are two distinct populations of mem-
ory CD4+  T cells, which are distinguished by the
expression of CCR7 [34]. One is CCR7high central memory
T cells which home preferentially to lymph nodes,
another is CCR7low effector memory cells which traffic
more efficiently to non-lymphoid tissues and acquire
effector function more rapidly [34,35]. Central memory T
cells express high levels of CD62L [34]. In contrast, effec-
tor memory T cells express CD62L to a lower and variable
extent [34]. Therefore, CD62Llow  memory T cells are
thought to be a subset of effector memory T cells [34,36].
We demonstrated that the CD62Llow subset proliferated
and produced Th2-type cytokines in response to OVA,
while the CD62Lhigh subset did not (Figure 9A and 9B).
Moreover, transferred CD62Llow subset recruited into the
lung, and proliferated there without local antigen chal-
lenge (Figure 9E and 9F). Therefore, in our system, some
antigen specific T cells could have acquired a memory/
effector phenotype (effector memory T cells), reached the
lung, proliferated and produced cytokines, then finally
induced AHR in an antigen free setting. Furthermore, local
antigen stimuli would further accelerate immune
response and thus airway eosinophilia would be induced
[37], which could further increase AHR (Figures 1A and
4A).
So far, whether immunocompetent cells would modify
intrinsic AHR has remained unclear. De Sanctis et al.
reported that T lymphocytes mediate intrinsic AHR [38].
However, Hadeiba et al. later reported that transfer of
CD4+ T cells that are not stimulated with antigen does not
alter the intrinsic AHR [39]. The latter finding is strongly
supported by the present findings that antigen-stimulated
cells mediated AHR induction, while cells that had not
encountered antigen did not.
In vitro OVA stimulation of OVA sensitized spleen cells
enhanced transfer activity to induce AHR (Figure 7A) and
cytokine concentration in BALF (Figure 7B). Wise et al.
reported that in vitro OVA stimulation enhances transfer
activity to provoke eosinophilic airway inflammation
[37]. We needed larger numbers of OVA-sensitized spleen
cells to induce AHR than other studies [17,18], because
we did not stimulate cells with OVA in vitro before transfer
in most part of this study. Spleen cells from OVA-sensi-
tized mice produced greater amount of cytokines upon
further stimulation with OVA in vitro (data not shown).
Therefore, the more Th2-type cytokine was produced by
transferred cells, the greater the intensity of AHR increased
(Figure 7).
Among cytokines produced by CD4+ Th2 cells, which is
most important for developing of AHR has not been fully
clarified. IL-13 is a candidate for developing AHR inde-
pendently of eosinophilic inflammation [12]. On the
other hand, some previous studies [10,40] including ours
[19] showed that IL-4 also plays an important role. In the
current study, IL-4 and IL-5 concentrations in BALF
increased by cell transfer (Figure 5), while IL-13 did not
increase significantly (data not shown). Moreover, trans-
fer of spleen cells from antigen-sensitized IL-4-deficient
mice did not induce AHR (Figure 6). So in the present
experimental system, IL-4 would play a major role. Airway
smooth muscle cells express IL-4Rα  [41,42]. We speculate
that one of the mechanisms of AHR induction by cell
transfer could be a direct influence on smooth muscle
cells [43]. The relationship between Th2 cytokine and
smooth muscle cell should be further elucidated. NKT
cells are another cell source of IL-4 [44-47] and IL-13 pro-
ductions [44], and would influence the subsequent adap-
tive immune response and T cell polarization [45,47]. The
development of AHR is abrogated in NKT-cell deficient
mice [44,46]. However, in the current study, iVα 14 NKT
cells did not influence this transfer-mediated AHR (Figure
8A). This indicates that although NKT cells might playRespiratory Research 2005, 6:46 http://respiratory-research.com/content/6/1/46
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some important role in a certain phase of sensitization,
once conventional T cells are activated and gain effector
function, iVα 14 NKT cells would have little contribution
to the induction of AHR.
Conclusion
In conclusion, the current study clarified the significance
of antigen-specific memory/effector CD4+ T cell-mediated
Th2-type immune response as an essential factor to
induce basal AHR in an antigen independent setting. It
would also propose that suppression of antigen-specific
immune response itself should be a critical target for con-
trolling allergic asthma.
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